The results obtained in this study showed that receiving oral silymarin in a 9-month treatment period leads to a slight significant decrease in serum levels of AST, ALT, bilirubin, and GGT in children with leukemia, but no significant effect was observed on cholesterol or albumin. Here, ALB is linked to leukemia.